In mice with adverse intestinal microbiota, oral probiotics containing Bifidobacterium could restore the anti-tumor effect of PD-L1 blockade, mainly by promoting the maturation of dendritic cells so as to improve the activity of tumor-specific CD8+ T cells (52). The gene discussed is CD8A; the disease is neoplasm.